Capricor Therapeutics, Inc. (CAPR) Stock Ticker
CAPR right now
Market factors today
Unlock the full CAPR picture
About Capricor Therapeutics, Inc.
Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.
CAPR stock facts
| Ticker symbol | CAPR |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $480.8M |
| CEO | Linda Marbán |
| Employees | 231 |
| Headquarters | San Diego, CA, US |
| IPO date | 2007-02-13 |
| Website | www.capricor.com |
What you can see for CAPR on Tickr
Live CAPR price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the CAPR report.
Rankings
FAQ
What is the ticker symbol for Capricor Therapeutics, Inc.?
The ticker symbol for Capricor Therapeutics, Inc. is CAPR, listed on the NASDAQ.
What is CAPR?
Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002,…